<DOC>
	<DOCNO>NCT00770575</DOCNO>
	<brief_summary>The purpose study determine effect pioglitazone , daily ( QD ) , atorvastatin combination therapy compare atorvastatin monotherapy patient risk cardiovascular disease .</brief_summary>
	<brief_title>Efficacy Study Pioglitazone Atorvastatin Combination Therapy Treating Subjects With Elevated Risk Cardiovascular Disease</brief_title>
	<detailed_description>Carotid intima-media thickness well described surrogate marker cardiovascular risk . A thickened carotid intima medium layer correlate presence cardiovascular risk factor also risk future macrovascular event myocardial infarction stroke . The interventional approach cardiovascular risk factor angiotensin convert enzyme system blocker , calcium antagonist beta blocker result reduction progression even net regression carotid intima-media thickness . The potent agent , however , statins consistently show effect carotid intima-media thickness patient hypercholesterolemia and/or atherosclerotic disease . Peroxisome proliferator activator receptor-gamma activation thiazolidinediones promise new approach reduces insulin resistance improves lipid profile . In addition metabolic activity , peroxisome proliferator activator receptor-gamma activator show exert anti-inflammatory effect , improve endothelial function inhibit atherogenesis diabetic non-diabetic atherosclerosis-prone animal model . Treatment peroxisome proliferator activator receptor-gamma agonist show reduce arterial pressure carotid intima-media thickness diabetic non-diabetic patient risk cardiovascular disease . The aim study evaluate effect Pioglitazone addition Atorvastatin compare Atorvastatin alone vascular risk marker intima-media thickness patient elevate risk cardiovascular disease .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Intimamedia thickness Common Carotid Artery great equal 0.8 mm ( least one side ) . Increased cardiovascular risk define one following : medical history infarction coronary angiography proven cardiovascular disease instable Angina pectoris duplexsonography cervical leg vessel prove atherosclerotic vascular alteration electrocardiogram ischemia stroke transient ischemic attack peripheral arterial occlusion vessel surgery hypertension ( RR great 140/90 ) antihypertensive high density lipoprotein less 40 mg/dl . Body mass index great equal 25 kg/m2 . Females childbearing potential sexually active must agree use adequate contraception , neither pregnant lactating Screening throughout duration study . History overt type2diabetes accord World Health Organization criterion . History type1diabetes . History one unexplained hypoglycemic episode within last 6 month . Statin therapy within last 4 week . Anamnestic history hypersensitivity study drug drug similar chemical structure . History severe multiple allergy . Treatment investigational drug within 3 month trial entry . Progressive fatal disease . Myopathy . Drug alcohol abuse within last 5 year . Smoker define patient evidence history tobacco nicotine use within last 6 month screen visit . A history heart failure ( New York Heart Association stage II IV ) significant respiratory , gastrointestinal , hepatic ( glutamatepyruvatetransaminase time great 2.5 time normal reference range ) , renal ( creatinine great 2.0 mg/dl ) hematological disease . Blood donation within last 30 day . Is required take intend continue take disallowed medication , prescription medication , herbal treatment overthe counter medication may interfere evaluation study medication , include : ciclosporin erythromycin clarithromycin itraconazole ketoconazole nefazodone niacin gemfibrozil fibrates HIVProteaseInhibitors Pretreatment thiazolidinediones within 3 month trial entry .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Biological Markers</keyword>
	<keyword>Biochemical Markers</keyword>
	<keyword>Carotid Artery , Internal</keyword>
	<keyword>Carotid Artery , Common</keyword>
	<keyword>Marker , Surrogate</keyword>
	<keyword>Vascular Diseases</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>